• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经营养性角膜病变问卷的开发:定性研究

Development of the neurotrophic keratopathy questionnaire: qualitative research.

作者信息

Murray Lindsey T, McCormack Julie, Grobeiu Ioana, Wiklund Ingela, Kimel Miriam, Van Nooten Floortje

机构信息

Evidera, 7101 Wisconsin Avenue, Suite 1400, Bethesda, MD, 20814, USA.

Dompé farmaceutici S.p.A, Via Santa Lucia, 6, 20122, Milan, MI, Italy.

出版信息

J Patient Rep Outcomes. 2020 May 4;4(1):30. doi: 10.1186/s41687-020-00192-y.

DOI:10.1186/s41687-020-00192-y
PMID:32367451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7198680/
Abstract

BACKGROUND

Neurotrophic keratopathy/keratitis (NK) is a rare disease of the cornea that can lead to anatomical loss of the eye. Little is known about the NK experience from the patients' perspective. The objectives of this study were to examine the symptomatic experience and impacts of NK on patients and assess the overall comprehension, relevance, and content validity of a new questionnaire.

METHODS

This was a cross-sectional, qualitative study conducted with NK patients with varying levels of disease severity, recruited from one clinical site. One-on-one interviews using concept elicitation and cognitive interviewing techniques were conducted.

RESULTS

Fourteen NK patients participated; 64.3% were female (n = 9), mean age was 65.7 ± 13.3, and 14.3% (n = 2), 21.4% (n = 3), and 64.3% (n = 9) were classified as Mackie stage I, stage II, or stage III, respectively. Participants reported 24 concepts, including: redness (n = 12, 86%), sensitivity to light (n = 11, 79%), general discomfort (n = 9, 64%), dry eye (n = 9, 64%), reduced visual acuity (n = 9, 64%), blurred vision (n = 8, 57%), and eye fatigue (n = 8, 57%). No new concepts were reported after the 13th interview. The most frequently reported impacts included frustration (n = 10, 71%), driving impairment (n = 8, 57%), reading impairment (n = 7, 50%), difficulty watching television (n = 7, 50%), and concern with potentially losing their eyesight due to NK (n = 6, 43%). Participants provided positive feedback on the draft NK Questionnaire (NKQ) and felt that it was comprehensive and relevant to their experience with NK. Additionally, the recall period, instructions, item concepts, and response options were well-understood by participants. Minor revisions were made to the tool for consistency (i.e., the timeframe "in the past 7 days" was added to items 12-14); item 14 was modified to include "how often"; examples were added to item 9.

CONCLUSIONS

The results of the concept elicitation portion of the qualitative study support the content validity of the draft NKQ. The clinically significant concepts identified in the literature and raised during concept elicitation are included as items in the questionnaire. Further assessment of the psychometric properties should be conducted in support of this new tool to measure the effect of new treatments on symptoms and impacts associated with NK.

摘要

背景

神经营养性角膜病变/角膜炎(NK)是一种罕见的角膜疾病,可导致眼球的解剖结构丧失。从患者角度对NK的了解甚少。本研究的目的是调查NK患者的症状体验及其对患者的影响,并评估一份新问卷的整体理解度、相关性和内容效度。

方法

这是一项横断面定性研究,从一个临床地点招募了疾病严重程度不同的NK患者。采用概念激发和认知访谈技术进行一对一访谈。

结果

14名NK患者参与研究;64.3%为女性(n = 9),平均年龄为65.7±13.3岁,14.3%(n = 2)、21.4%(n = 3)和64.3%(n = 9)的患者分别被归类为麦基I期、II期或III期。参与者报告了24个概念,包括:眼红(n = 12,86%)、畏光(n = 11,79%)、全身不适(n = 9,64%)、干眼(n = 9,64%)、视力下降(n = 9,64%)、视物模糊(n = 8,57%)和眼疲劳(n = 8,57%)。第13次访谈后未报告新的概念。最常报告的影响包括沮丧(n = 10,71%)、驾驶障碍(n = 8,57%)、阅读障碍(n = 7,50%)、看电视困难(n = 7,50%)以及担心因NK而可能失明(n = 6,43%)。参与者对NK问卷初稿(NKQ)给予了积极反馈,并认为它全面且与他们的NK经历相关。此外,参与者对回忆期、说明、项目概念和回答选项理解良好。对该工具进行了一些小的修订以保持一致性(例如,在第12 - 14项中添加了“在过去7天内”的时间范围);第14项进行了修改以包括“频率如何”;第9项添加了示例。

结论

定性研究的概念激发部分结果支持了NKQ初稿的内容效度。文献中确定并在概念激发过程中提出的具有临床意义的概念被纳入问卷项目。应进一步评估该工具的心理测量特性,以支持这一用于测量新治疗对与NK相关的症状和影响的新工具。

相似文献

1
Development of the neurotrophic keratopathy questionnaire: qualitative research.神经营养性角膜病变问卷的开发:定性研究
J Patient Rep Outcomes. 2020 May 4;4(1):30. doi: 10.1186/s41687-020-00192-y.
2
Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease.干眼疾病问卷在干眼疾病、睑板腺功能障碍和干燥综合征干眼疾病患者中的开发和内容效度评估。
J Patient Rep Outcomes. 2023 Jul 5;7(1):64. doi: 10.1186/s41687-023-00608-5.
3
Qualitative Research to Understand the Patient Experience and Evaluate Content Validity of the Chronic Ocular Pain Questionnaire (COP-Q).质性研究以了解患者体验并评估慢性眼痛问卷(COP-Q)的内容效度。
Ophthalmol Ther. 2024 Feb;13(2):615-633. doi: 10.1007/s40123-023-00860-4. Epub 2024 Jan 6.
4
Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS Short Forms: a study in patients with axial spondyloarthritis.对症状、影响和选定的定制 PROMIS 短表进行定性概念发掘和认知性访谈:一项中轴型脊柱关节炎患者的研究。
J Patient Rep Outcomes. 2023 Apr 20;7(1):39. doi: 10.1186/s41687-023-00575-x.
5
Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.FSIQ-RMS 的制定与验证:一种新的患者报告问卷,用于评估复发型多发性硬化症的疲劳症状和影响。
Value Health. 2019 Apr;22(4):453-466. doi: 10.1016/j.jval.2018.11.007. Epub 2019 Feb 21.
6
Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.肺动脉高压-症状与影响(PAH-SYMPACT®)问卷的开发:一种新的肺动脉高压患者报告结局工具。
Respir Res. 2016 Jun 14;17(1):72. doi: 10.1186/s12931-016-0388-6.
7
Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials.开发一种评估慢性下背痛影响的问卷,用于监管临床试验。
Patient. 2013;6(4):291-305. doi: 10.1007/s40271-013-0026-z.
8
The Vulvodynia Experience Questionnaire: Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia.《阴部疼痛体验问卷》:一种新的阴部疼痛患者报告结局测量工具的定性研究。
J Sex Med. 2020 Oct;17(10):2055-2066. doi: 10.1016/j.jsxm.2020.07.010. Epub 2020 Sep 6.
9
Evaluation of the content validity of patient-reported outcome (PRO) instruments developed for use with individuals with phakic presbyopia, including the Near Activity Visual Questionnaire-presbyopia (NAVQ-P) and the near vision correction independence (NVCI) instrument.对为有晶状体性老视患者开发的患者报告结局(PRO)工具的内容效度进行评估,这些工具包括近距活动视觉问卷-老视(NAVQ-P)和近视力矫正独立性(NVCI)工具。
J Patient Rep Outcomes. 2021 Oct 23;5(1):109. doi: 10.1186/s41687-021-00379-x.
10
Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures.定性探索色素性视网膜炎和莱伯先天性黑矇患者的视觉功能障碍及其对视依赖日常生活活动的影响:ViSIO-PRO 和 ViSIO-ObsRO 测量的内容验证。
J Patient Rep Outcomes. 2023 Jul 19;7(1):74. doi: 10.1186/s41687-023-00610-x.

引用本文的文献

1
Health-related quality of life questionnaire for corneal anaesthesia patients: a content validity assessment.角膜麻醉患者健康相关生活质量问卷:内容效度评估
Eye (Lond). 2025 Sep 1. doi: 10.1038/s41433-025-03969-x.
2
Systematic analysis of factors affecting the efficacy of corneal reinnervation surgery in treating neurotrophic keratitis.影响角膜再支配手术治疗神经营养性角膜炎疗效的因素的系统分析。
Eur J Med Res. 2025 Aug 13;30(1):742. doi: 10.1186/s40001-025-02992-8.
3
Topical Insulin for Neurotrophic-Related Epithelial Defects: Where do We Stand? A Systematic Review.用于神经营养相关上皮缺损的局部胰岛素:我们目前的状况如何?一项系统评价
J Curr Ophthalmol. 2024 Oct 16;36(1):9-22. doi: 10.4103/joco.joco_32_24. eCollection 2024 Jan-Mar.
4
Neurotrophic keratopathy: current challenges and future prospects.神经营养性角膜病变:当前的挑战与未来展望。
Ann Med. 2022 Dec;54(1):666-673. doi: 10.1080/07853890.2022.2045035.
5
Incidence, prevalence, and outcome of moderate to severe neurotrophic keratopathy in a German tertiary referral center from 2013 to 2017.2013年至2017年德国一家三级转诊中心中重度神经营养性角膜病变的发病率、患病率及转归
Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1961-1973. doi: 10.1007/s00417-021-05535-z. Epub 2022 Jan 6.

本文引用的文献

1
Neurotrophic keratopathy.神经营养性角膜病变。
Prog Retin Eye Res. 2018 Sep;66:107-131. doi: 10.1016/j.preteyeres.2018.04.003. Epub 2018 Apr 23.
2
Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.人神经生长因子治疗神经营养性角膜病变的随机、双盲、载体对照 II 期临床试验
Ophthalmology. 2018 Sep;125(9):1332-1343. doi: 10.1016/j.ophtha.2018.02.022. Epub 2018 Apr 10.
3
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report.罕见病临床试验中的患者报告结局和观察者报告结局评估:一份ISPOR COA新兴良好实践工作组报告。
Value Health. 2017 Jul-Aug;20(7):838-855. doi: 10.1016/j.jval.2017.05.015.
4
Congenital Corneal Anesthesia and Neurotrophic Keratitis: Diagnosis and Management.先天性角膜麻醉与神经营养性角膜炎:诊断与治疗
Biomed Res Int. 2015;2015:805876. doi: 10.1155/2015/805876. Epub 2015 Sep 16.
5
Patient-Focused Drug Development: A New Direction for Collaboration.以患者为中心的药物研发:合作的新方向。
Med Care. 2015 Jan;53(1):9-17. doi: 10.1097/MLR.0000000000000273.
6
Recurrent nontuberculous mycobacterial endophthalmitis: a diagnostic conundrum.复发性非结核分枝杆菌性眼内炎:一个诊断难题。
Clin Ophthalmol. 2014 May 2;8:837-42. doi: 10.2147/OPTH.S56670. eCollection 2014.
7
Diagnosis and management of neurotrophic keratitis.神经营养性角膜炎的诊断与治疗
Clin Ophthalmol. 2014 Mar 19;8:571-9. doi: 10.2147/OPTH.S45921. eCollection 2014.
8
Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010).评估 FDA 与 EMA(2006-2010 年)相比授予的 PRO 标签声明。
Value Health. 2013 Dec;16(8):1150-5. doi: 10.1016/j.jval.2013.08.2293. Epub 2013 Oct 17.
9
Neurotrophic keratitis.神经营养性角膜炎。
Ophthalmologica. 2014;231(4):191-7. doi: 10.1159/000354380. Epub 2013 Oct 2.
10
The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda.以患者为中心的结果研究协会(PCORI)的国家研究重点及初步研究议程。
JAMA. 2012 Apr 18;307(15):1583-4. doi: 10.1001/jama.2012.500.